NeuroSense Therapeutics NRSN Financials and Fundamentals Overview
ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NRSN NeuroSense Therapeutics Ltd

1.04
-0.0779 (-6.97%)
11 Jan 2025 - Closed
Delayed by 15 minutes

NeuroSense Therapeutics Financial Summary

The current NRSN market cap is 20.25M. The company's latest EPS is USD -0.5794 and P/E is -0.90.

Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -1.24M-2.89M-5.59M-13.55M-13.3M
Net Income -1.22M-2.83M-4.04M-12.34M-11.28M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 955k779k11.43M7.71M3.18M
Total Liabilities 37k120k2.43M2.09M5.05M
Total Equity 918k659k9.01M5.62M-1.87M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -582k-695k-1.54M-7.59M-8.45M
Investing -26k-9k-17k-3.54M3.65M
Financing 1.42M508k11.9M3.7M3.9M
Market Cap 20.25M
Price to Earnings Ratio -0.90
Price to Sales Ratio 0
Price to Cash Ratio 3.83
Price to Book Ratio -5.4
Dividend Yield -

Share Statistics

Shares Outstanding 19.47M
Average Volume (1 week) 112.13k
Average Volume (1 Month) 483.65k
52 Week Change 26.98%
52 Week High 2.33
52 Week Low 0.512
Spread (Intraday) 0.1 (8.77%)

Company Info

Company Name NeuroSense Therapeutics Ltd
Address medinat ha-yehudim street, 85
herzliya, center
Website https://www.neurosense-tx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock